期刊文献+

运脾化痰方加减治疗肥胖型多囊卵巢综合征临床观察 被引量:15

Clinical effects of modif ied Yunpi Huatan Decoction on obese patients with polycystic ovary syndrome
原文传递
导出
摘要 目的:观察运脾化痰方加减治疗肥胖型多囊卵巢综合征(PCOS)的临床疗效。方法:将60例肥胖型PCOS患者随机分为治疗组和对照组各30例,治疗组予运脾化痰方加减,对照组服用二甲双胍,均治疗3个月。观察治疗后月经改善情况,性激素水平、体质量指数(BMI)、腰臀比(WHR)及糖脂代谢指标变化。结果:治疗后治疗组月经改善情况明显优于对照组(P<0.05),患者促黄体生成素(LH)、睾酮(T)、空腹胰岛素(FINS)、低密度脂蛋白胆固醇(LDL)均显著下降(P<0.01),BMI、WHR、稳态模型指数(HOMA-IR)、总胆固醇(TC)明显下降(P<0.05),其中睾酮下降情况明显优于对照组(P<0.05)。结论:运脾化痰方加减能很好地改善肥胖型PCOS患者月经情况及性激素水平,有效调节糖脂代谢。 Objective:To investigate the effects of modified Yunpi Huatan Decoction on obese patients with polycystic ovary syndrome(PCOS).Methods:60 Cases of PCOS were divided into treatment group with 30 patients and control group with 30 patients randomly.Treatment group was given modified Yunpi Huatan Decoction and the control group was given Metformin.Both had treatment period of three months.To observe the improving of menstruation,level of hormone,BMI,WHR and index change of glucose and lipid metabolism.Results:After three months,treatment group was superior to the control group in improving menstruation(P〈0.05).The value of LH,T,FINS,LDL declined significantly(P〈0.01).BMI,WHR,HOMA-IR and TC declined apparently(P〈0.05),the decline of testosterone was superior to control group(P〈0.05).Conclusion:Modified Yunpi Huatan Decoction can commendably improve menstruation and level of sex hormone for patients with obese PCOS,can adjust glucose and lipid metabolism efficiently.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2010年第5期768-770,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 多囊卵巢综合征 肥胖 二甲双胍 运脾化痰方 Polycystic ovary syndrome Obese Metformin Modifi ed Yunpi Huatan Decoction
  • 相关文献

参考文献2

二级参考文献20

  • 1李昕,林金芳.肥胖型多囊卵巢综合征患者临床及内分泌代谢特征的研究[J].中华医学杂志,2005,85(46):3266-3271. 被引量:141
  • 2林金芳,李昕,朱铭伟.多囊卵巢综合征的分型探讨[J].中华妇产科杂志,2006,41(10):684-688. 被引量:74
  • 3Bridger T,MacDonald S,Baltzer F,et al.Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome[J].Arch Pediatr Adolesc Med,2006,160(3):241-246.
  • 4Sahin I,Serter R,Karakurt F,et al.Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome:a randomized prospective study[J].Gynecol Endocrinol,2004,19 (3):115-124.
  • 5Eisenhart S,Schwarzmann N.Early effects of metformin in women with polycystic ovary syndrome:a prospective randomized,double-blind,placebo-controlled trial[J].J Clin Endocrinol Metab,2006,91:946-952.
  • 6Antonio LM,Alfredo CA,Gaspare S,et al.Metformin treatment of PCOS during adolescence and the reproductive period[J].Eur J Obstet Gynecol Reprod Biol,2005,121 (1):3-7.
  • 7Lehmann JM,Moore LB,Smith-Oliver TA,et al.An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor-γ[J].J Biol Chem,1995,270 (22):12953-12956.
  • 8Garmes HM,Tambascia MA,Zantut-Wittmann DE.Endocrinometabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome[J].Gynecol Endocrinol,2005,21 (6):317-323.
  • 9Ortega-Gonzalez C,Luna S,Hernandez L,et al.Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese,insulin-resistant women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2005,90 (3):1360-1365.
  • 10Glueck CJ,Moreira A,Goldenberg N,et al.Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin[J].Hum Reprod,2003,18(8):1618-1625.

共引文献72

同被引文献264

引证文献15

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部